Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Open Access

Figure S4 from NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1-Mutant Melanoma

View Full Paper
Ask AI
Bookmark
Share

Authors

MIMilad IbrahimIIIrineu Illa-BochacaGJGeorge Jour

Discussion

Loading...

Member takes

Overview

Loss of NF1 increases EGFR activity in melanoma, suggesting it plays a role in treatment sensitivity to EGFR inhibitors.

Key Points

  • NF1 loss enhances EGFR H3K4Me3 promoter activity, leading to increased EGFR activation.
  • The activation of EGFR due to NF1 loss makes melanoma cells more sensitive to EGFR inhibition.
  • Findings indicate a potential therapeutic target for NF1-mutant melanoma through EGFR inhibition.
  • Further exploration could unveil critical pathways for enhancing treatment strategies against melanoma.

Cite This Study

Ibrahim et al. (2025) studied this question.

synapsesocial.com/papers/68c23a2cb210217d6477fbc0https://doi.org/10.1158/0008-5472.30029882
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Figure S3 from NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1-Mutant Melanoma2025
  2. 2Figure S2 from NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1-Mutant Melanoma2025
  3. 3Figure S5 from NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1-Mutant Melanoma2025
  4. 4Table S2 from NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1-Mutant Melanoma2025
  5. 5Table S7 from NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1-Mutant Melanoma2025